ArticlePlant biotechnology journal2026
Staurosporine Targets Mitochondrial Regulator VdAtuA3 to Disrupt Mitochondrial Homeostasis to Control Verticillium Wilt.
Article in Plant biotechnology journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Mitochondria serve as cellular powerhouses that generate ATP via electron transport chain complexes and orchestrate metabolism-apoptosis cross-talk, yet genes maintaining mitochondrial homeostasis remain underexplored as antifungal targets. In this study, a previously uncharacterised protein VdAtuA3 was identified as a novel interactor with VdNuo1 (NADH: ubiquinone oxidoreductase 24-kDa subunit), defining a regulatory axis for the mitochondrial respiratory chain in Verticillium dahliae. Notably, VdNuo1 is highly conserved across plants, animals, and humans, consistent with its essential role in respiration, whereas VdAtuA3 homologues in non-fungal organisms share very low sequence similarity. Moreover, Y2H assays confirmed no interaction between Nuo1 and AtuA homologues from above organisms, indicating that this regulatory axis is specific to V. dahliae. The pathogen virulence factor VdAtuA3 and VdNuo1 co-regulate oxidative phosphorylation and superoxide detoxification, thereby promoting mitochondrial homeostasis. Staurosporine (STS), a natural microbial product, targets VdAtuA3, inhibiting its function and reducing the interaction between VdAtuA3 and VdNuo1, inducing mitochondrial dysfunction in V. dahliae, and suppressing its growth effectively controls Verticillium wilt. STS shows high efficacy with minimal off-target toxicity and can be safely applied to cotton, zebrafish, and human cells at fungistatic doses. Its broad-spectrum activity against multiple filamentous fungi, consistent with its high binding affinity to AtuA homologues from various filamentous fungi as demonstrated by molecular docking and functional complementation assays, further supports its potential as a promising antifungal agent. Our study provides a proof-of-concept for targeting pathogen-specific virulence factors that regulate mitochondrial homeostasis as a novel strategy to manage fungal plant pathogens.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.